Active Ingredient: HALOPERIDOL LACTATE
Proprietary Name: HALOPERIDOL
Dosage Form; Route of Administration: CONCENTRATE; ORAL
Strength: EQ 2MG BASE/ML
Reference Listed Drug: No
Reference Standard: No
TE Code: AA
Application Number: A218371
Product Number: 001
Approval Date: Jan 31, 2024
Applicant Holder Full Name: RUBICON RESEARCH PRIVATE LTD
Marketing Status:
Prescription
Patent and Exclusivity Information